Christopher Stevens
Fortune : 1 M $ au 31/05/2026
Fortune : 1 M $ au 31/05/2026
Christopher Stevens is Chief Operating Officer at Rocket Pharmaceuticals, Inc. since 2025.
Formerly, Mr. Stevens was Chief Patent Supply Officer & Executive VP at Spark Therapeutics, Inc. from 2022 to 2025.
Education includes undergraduate studies at Purdue University and graduate studies at the University of Southern Indiana.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/02/2026 | 469 129 ( 0,43 % ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Directeur des opérations | 07/07/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/07/2025 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern Indiana
University of Southern Indiana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national